PCI is an integrated, full-service pharmaceutical provider whose molecule-to-market offering takes compounds from the earliest stages of development through commercial launch, delivering speed to market and commercial success for customers. Core services include analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, and storage and distribution, with facilities enabling safe development and clinical/commercial supply of potent products down to an OEL of 0.01 μg/m3; customers can use PCI as a complete development partner or select any core service as a stand-alone offering, with a comprehensive pharmaceutical development service including early-stage formulation and analytical development, drug-in-capsule/vial filling using Xcelodose technology, scale-up and process validation, and technology transfer.
Aucun commentaire disponible.
Laissez votre note & commentaire